healthy population
Conditions
Interventions
Test group:Accept a 56-day trial product regimen
Sponsors
Central Hospital of Fengxian District, Shanghai
Eligibility
Sex/Gender
All
Age
25 Years to 55 Years
Inclusion criteria
Inclusion criteria: (1) Age between 25 and 55 years (inclusive), etc.; (2) Visual assessment of subjects conducted by personnel who have been trained and passed the wrinkle grading evaluation, with periorbital wrinkles meeting the "Standard for Evaluation of Human Skin Aging" scoring grade >=2 and facial skin yellowness grade on the scale >=3; (3) Subjects seeking improvement in skin roughness, dryness, and dull complexion; (4) Ability to fully cooperate with the trial and maintain regular lifestyle during the testing period; (5) Agreement not to use any cosmetics, medications, or supplements that may affect test results during the testing period, such as collagen, hyaluronic acid, niacinamide, salicylic acid, or any combination thereof in dietary supplements; (6) Ability to understand the trial procedure, willingness to participate voluntarily, and signing of a written informed consent form.
Exclusion criteria
Exclusion criteria: (1) Individuals who are currently pregnant or lactating, or planning to become pregnant during the study period. (2) Individuals with known allergies to the test product. (3) Patients suffering from severe diseases of the heart, liver, kidneys, hematopoietic system, or other major organ systems. (4) Individuals with psychiatric disorders or severe endocrine diseases (such as uncontrolled diabetes, hypertension, or other chronic systemic diseases). (5) Individuals with facial skin conditions that may interfere with the assessment of trial results. (6) Individuals who have participated in drug clinical trials or other trials within the past month, or who have recently consumed products related to the tested function, thereby affecting result evaluation. (7) Individuals who do not meet inclusion criteria, who fail to consume the test product as instructed, or whose efficacy or safety cannot be properly evaluated due to incomplete data. (8) Individuals deemed unsuitable for participation by clinical assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin melanin content ;Skin color ITA° value ;Skin b* value test;AGEs level;Skin glossiness;Stratum corneum moisture content;Skin collagen density;Skin elasticity;Skin roughness;Facial image capture and analysis; | — |
Countries
China
Contacts
Public ContactZhu Haiying
Central Hospital of Fengxian District, Shanghai
Outcome results
None listed